Epigenetic therapy with chidamide alone or combined with 5‑azacitidine exerts antitumour effects on acute myeloid leukaemia cells <i>in vitro</i>-Reference-Cited by-同舟云学术

Epigenetic therapy with chidamide alone or combined with 5‑azacitidine exerts antitumour effects on acute myeloid leukaemia cells in vitro

Published:2022-01-31 Issue:4 Volume:47 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Li Zheng¹,Zhang Jian²,Zhou Min³,Li Jin-Li⁴,Qiu Qiao-Cheng¹,Fu Jian-Hong¹,Xue Sheng-Li¹,Qiu Hui-Ying¹

Affiliation:

1. National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China

2. Department of Blood Transfusion, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China

3. Department of Hematology, Changshu Affiliated Hospital of Soochow University, The First People's Hospital of Changshu, Changshu, Jiangsu 215500, P.R. China

4. State Key Laboratory of Radiation Medicine and Protection, Oncology Radiotherapy Department, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference38 articles.

1. Cancer epigenetics: From mechanism to therapy;Dawson;Cell,2012

2. Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia;Bhatla;Blood,2012

3. A decade of exploring the cancer epigenome-biological and translational implications;Baylin;Nat Rev Cancer,2011

4. Driver mutations of cancer epigenomes;Roy;Protein Cell,2014

5. Epigenetic regulators in the development, maintenance, and therapeutic targeting of acute myeloid leukemia;Sun;Front Oncol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chidamide induces cell cycle arrest via NR4A3/P21 axis upregulation to suppress relapsed and refractory acute myeloid leukemia;Biochemical and Biophysical Research Communications;2024-12

2. Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT;Annals of Hematology;2024-06-22

3. Application of Histone Deacetylase Inhibitor in Acute Myeloid Leukemia;PROG BIOCHEM BIOPHYS;2024

4. Simvastatin prevents BMP-2 driven cell migration and invasion by suppressing oncogenic DNMT1 expression in breast cancer cells;Gene;2023-10

5. Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study;Hematology;2023-06-06